UBS O'Connor’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

UBS O'Connor’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-142,301	Closed	-$1.47M	–	652
2023 Q2	$1.47M	Sell	142,301 -3,239	-2%	-$33.2K	0.03%	342
2023 Q1	$1.5M	Buy	+145,540	New	+$1.48M	0.04%	368
2022 Q4	–	Sell	-325,945	Closed	-$3.2M	–	473
2022 Q3	$3.2M	Sell	325,945 -33,335	-9%	-$327K	0.04%	428
2022 Q2	$3.51M	Buy	+359,280	New	+$3.51M	0.04%	433
2022 Q1	–	Sell	-352,824	Closed	-$3.42M	–	330
2021 Q4	$3.42M	Buy	352,824 +2,595	+0.7%	+$25.3K	0.03%	386
2021 Q3	$3.4M	Hold	350,229	–	–	0.03%	405
2021 Q2	$3.4M	Buy	+350,229	New	+$3.43M	0.03%	366

Other funds holding AONC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS O'Connor's AONC Position: Q3 2023 in Review

UBS O'Connor sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2023, closing a stake of 142,301 shares — an estimated $1.47M sold.

UBS O'Connor first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $3.51M in Q2 2022. 3 funds tracked by Wall St. Rank hold AONC as of Q3 2023.

UBS O'Connor reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
UBS O'Connor sold 142,301 American Oncology Network, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.47M.
UBS O'Connor first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
UBS O'Connor's American Oncology Network, Inc. Class A Common Stock position peaked at $3.51M in Q2 2022.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.